Literature DB >> 32331503

Using Crowdsourced Listeners' Ratings to Measure Speech Changes in Hypokinetic Dysarthria: A Proof-of-Concept Study.

Christopher Nightingale1, Michelle Swartz2, Lorraine Olson Ramig3,4,5,6, Tara McAllister1.   

Abstract

Purpose Interventions for speech disorders aim to produce changes that are not only acoustically measurable or perceptible to trained professionals but are also apparent to naive listeners. Due to challenges associated with obtaining ratings from suitably large listener samples, however, few studies currently evaluate speech interventions by this criterion. Online crowdsourcing technologies could enhance the measurement of intervention effects by making it easier to obtain real-world listeners' ratings. Method Stimuli, drawn from a published study by Sapir et al. ("Effects of intensive voice treatment (Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: Acoustic and perceptual findings" in Journal of Speech, Language, and Hearing Research, 50(4), 2007), were words produced by individuals who received intensive treatment (LSVT LOUD) for hypokinetic dysarthria secondary to Parkinson's disease. Thirty-six online naive listeners heard randomly ordered pairs of words elicited pre- and posttreatment and reported which they perceived as "more clearly articulated." Results Mixed-effects logistic regression indicated that words elicited posttreatment were significantly more likely to be rated "more clear." Across individuals, acoustically measured magnitude of change was significantly correlated with pre-post difference in listener ratings. Conclusions These results partly replicate the findings of Sapir et al. (2007) and demonstrate that their acoustically measured changes are detectable by everyday listeners. This supports the viability of using crowdsourcing to obtain more functionally relevant measures of change in clinical speech samples. Supplemental Material https://doi.org/10.23641/asha.12170112.

Entities:  

Mesh:

Year:  2020        PMID: 32331503      PMCID: PMC7842862          DOI: 10.1044/2019_AJSLP-19-00162

Source DB:  PubMed          Journal:  Am J Speech Lang Pathol        ISSN: 1058-0360            Impact factor:   2.408


  26 in total

1.  Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.

Authors:  Kris Tjaden; Joan E Sussman; Gregory E Wilding
Journal:  J Speech Lang Hear Res       Date:  2014-06-01       Impact factor: 2.297

2.  Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.

Authors:  Shimon Sapir; Jennifer L Spielman; Lorraine O Ramig; Brad H Story; Cynthia Fox
Journal:  J Speech Lang Hear Res       Date:  2007-08       Impact factor: 2.297

3.  Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment.

Authors:  Shimon Sapir; Lorraine O Ramig; Patricia Hoyt; Stefanie Countryman; Christopher O'Brien; Margaret Hoehn
Journal:  Folia Phoniatr Logop       Date:  2002 Nov-Dec       Impact factor: 0.849

4.  Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.

Authors:  Christina H Smith; Smitaa Patel; Rebecca L Woolley; Marian C Brady; Caroline E Rick; Rhiannon Halfpenny; Alexia Rontiris; Lucy Knox-Smith; Francis Dowling; Carl E Clarke; Pui Au; Natalie Ives; Keith Wheatley; Catherine M Sackley
Journal:  Clin Linguist Phon       Date:  2019-04-29       Impact factor: 1.346

5.  Systematic Review: Online Crowdsourcing to Assess Perceptual Speech Outcomes.

Authors:  Anne M Sescleifer; Caitlin A Francoisse; Alexander Y Lin
Journal:  J Surg Res       Date:  2018-07-18       Impact factor: 2.192

6.  Comparison of two forms of intensive speech treatment for Parkinson disease.

Authors:  L O Ramig; S Countryman; L L Thompson; Y Horii
Journal:  J Speech Hear Res       Date:  1995-12

7.  The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.

Authors:  Gemma Moya-Galé; Alireza Goudarzi; Àngels Bayés; Megan McAuliffe; Bram Bulté; Erika S Levy
Journal:  Am J Speech Lang Pathol       Date:  2018-02-06       Impact factor: 2.408

8.  Online crowdsourcing for efficient rating of speech: a validation study.

Authors:  Tara McAllister Byun; Peter F Halpin; Daniel Szeredi
Journal:  J Commun Disord       Date:  2014-12-15       Impact factor: 2.288

9.  Use of Crowdsourcing to Assess the Ecological Validity of Perceptual-Training Paradigms in Dysarthria.

Authors:  Kaitlin L Lansford; Stephanie A Borrie; Lukas Bystricky
Journal:  Am J Speech Lang Pathol       Date:  2016-05-01       Impact factor: 2.408

10.  Speech treatment in Parkinson's disease: Randomized controlled trial (RCT).

Authors:  Lorraine Ramig; Angela Halpern; Jennifer Spielman; Cynthia Fox; Katherine Freeman
Journal:  Mov Disord       Date:  2018-09-28       Impact factor: 10.338

View more
  3 in total

1.  Intelligibility Across a Reading Passage: The Effect of Dysarthria and Cued Speaking Styles.

Authors:  Frits van Brenk; Kaila Stipancic; Alexander Kain; Kris Tjaden
Journal:  Am J Speech Lang Pathol       Date:  2022-01-04       Impact factor: 4.018

2.  Investigating Acoustic Correlates of Intelligibility Gains and Losses During Slowed Speech: A Hybridization Approach.

Authors:  Frits van Brenk; Alexander Kain; Kris Tjaden
Journal:  Am J Speech Lang Pathol       Date:  2021-05-28       Impact factor: 2.408

3.  Single Word Intelligibility of Individuals with Parkinson's Disease in Noise: Pre-Specified Secondary Outcome Variables from a Randomized Control Trial (RCT) Comparing Two Intensive Speech Treatments (LSVT LOUD vs. LSVT ARTIC).

Authors:  Geralyn Schulz; Angela Halpern; Jennifer Spielman; Lorraine Ramig; Ira Panzer; Alan Sharpley; Katherine Freeman
Journal:  Brain Sci       Date:  2021-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.